Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

European Court asked to review notified body liability post-PIP: landmark medtech case

This article was originally published in Clinica

Executive Summary

The Court of Justice of the European Union (CJEU) is considering one of the most far-reaching questions it is likely to address concerning liability in the European medical devices sector this decade. The issue concerns the highly disputed question of the liability of notified bodies. Dr Dr Adem Koyuncu of Covington & Burling LLP looks at the potential impact of this case, and also reflects on the recent 5 March CJEU ruling which has expanded manufacturers’ liability risks too.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT102551

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel